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Hypoxia has been implicated as a crucial microenvironmental factor that induces cancer metastasis. We previously
reported that hypoxia could promote gastric cancer (GC) metastasis, but the underlying mechanisms are not clear.
Long noncoding RNAs (lncRNAs) have recently emerged as important regulators of carcinogenesis that act on
multiple pathways. However, whether lncRNAs are involved in hypoxia-induced GC metastasis remains unknown.
In this study, we investigated the differentially expressed lncRNAs resulting from hypoxia-induced GC and
normoxia conditions using microarrays and validated our results through real-time quantitative polymerase chain
reaction. We found an lncRNA, AK058003, that is upregulated by hypoxia. AK058003 is frequently upregulated in
GC samples and promotes GC migration and invasion in vivo and in vitro. Furthermore, AK058003 can mediate the
metastasis of hypoxia-induced GC cells. Next, we identified γ-synuclein (SNCG), which is a metastasis-related gene
regulated by AK058003. In addition, we found that the expression of SNCG is positively correlated with that of
AK058003 in the clinical GC samples used in our study. Furthermore, we found that the SNCG gene CpG island
methylation was significantly increased in GC cells depleted of AK058003. Intriguingly, SNCG expression is also
increased by hypoxia, and SNCG upregulation by AK058003 mediates hypoxia-induced GC cell metastasis. These
results advance our understanding of the role of lncRNA-AK058003 as a regulator of hypoxia signaling, and this
newly identified hypoxia/lncRNA-AK058003/SNCG pathway may help in the development of new therapeutics.
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Gastric cancer (GC) is one of the most common human cancers and
the second leading cause of cancer-related mortality worldwide [1].
The major cause of death is metastasis, which greatly hinders
treatment success [2]. Hypoxia is an important microenvironmental
factor that induces such metastasis. In fact, hypoxic tumors are often
aggressive and more likely to metastasize [3]. Therefore, investigating
the underlying mechanisms of hypoxia-induced metastasis is critical.
We have previously performed studies exploring the mechanism
underlying GC pathogenesis under hypoxic stress, with a focus on
protein-coding genes [4–6]. However, protein-coding genes account
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transcribed into non-coding RNAs (ncRNAs) [7,8]. Recently, long
noncoding RNAs (lncRNAs) have been reported to be associated with
hypoxia-induced cancer development [9] and to contribute to
hypoxia-mediated HepatoCellular Carcinoma metastasis [10].
LncRNAs have been identified as a new class of functional ncRNAs
and have kindled our interest. lncRNAs are defined as transcripts of
longer than 200 nucleotides without evident protein-coding function
[11]. Few studies have implicated lncRNAs in various cancers
[12,13], and several of the altered lncRNAs can result in the aberrant
expression of nearby protein-coding genes, which may contribute to
cancer development [14–16]. Studies have also demonstrated that
lncRNAs play an important role in tumor development via various
mechanisms, such as chromatin remodeling [17], DNA methylation
[18], transcriptional regulation [19], and DNA damage repair
[14,20]. All related processes play a pivotal role in malignant
transformation and cancer treatment. However, the function of most
lncRNAs in cancer remains a mystery, and lncRNA profiles in
hypoxic GC and hypoxia-responsive gene networks remain unknown.
Prototypical lncRNAs have been shown to be overexpressed in
subsets of cancers, to interact with epigenetic complexes [17], to be
recruited to DNA sequences as enhancers, and to regulate
transcription [19,21] and DNA methylation [18,22]. To explore
the role of lncRNAs in hypoxic GC, we identified a small number of
lncRNAs and messenger RNAs (mRNAs) that are aberrantly
expressed in GC under hypoxia compared with normoxia using
microarrays. We also investigated the biological function of the
hypoxia-upregulated AK058003 both in vivo and in vitro. The
synuclein family consists of three distinct highly homologous genes,
α-synuclein, β-synuclein, and γ-synuclein (SNCG), which have been
well studied in connection with cancer [23]. Further analysis
demonstrated that SNCG is overexpressed in several types of cancer
[24]. In our study, the inhibition of lncRNA-AK058003 and SNCG
was found to play an important role in hypoxia-induced metastasis
and invasion, suggesting that manipulating new ncRNA functions
can provide a therapeutic opportunity that is worth exploring.Materials and Methods
Ethics Statement
For tissue specimens, signed informed consent was obtained from
the patients who contributed dissected tissues. All GC cases were
clinically and pathologically confirmed. The experimental procedures
were approved by the Institutional Review Board of the Fourth
Military Medical University and conformed to the Helsinki
Declaration and local legislation. All animal experiments were
performed in accordance with national guidelines for the care and
use of laboratory animals and with the approval of the Institutional
Committee for Animal Research.
Human lncRNA Microarray
Various cell lines (three normoxia-induced GC cell lines and three
corresponding hypoxia-induced GC cell lines) were used for human
lncRNA microarray analysis. Briefly, total RNA was extracted using
TRIzol reagent (Invitrogen, Carlsbad, CA) and quantified using a
NanoDrop ND-1000. The RNA integrity was assessed using
standard denaturing agarose gel electrophoresis [25]. Approximately
5 μg total RNA from each sample was used to synthesize double-
stranded cDNA, which was labeled and hybridiszd to the 12x135KHuman lncRNA Expression Microarray (Arraystar, Rockville, MD).
After hybridization and washing, array scanning was performed with
an Axon GenePix 4000B microarray scanner. The acquired array
images were analyzed with NimbleScan software (version 2.5). The
expression data were normalized via quantile normalization and using
the RMA algorithm included in the software. Differentially expressed
lncRNAs and mRNAs were identified through fold-change filtering.
Finally, hierarchical clustering was performed to show the differential
lncRNA and mRNA expression pattern among samples.
Clinical Samples
Twenty pairs of human primary GC and matched noncancerous
adjacent gastric tissues were collected at Xijing Hospital, Xi’an,
China. Clinicopathologic features, including sex, age, tumor
differentiation, tumor stage, and distant metastasis, are listed in
Supplementary Table 2. All tissue samples were freshly frozen at
−80°C. Total RNA from the frozen tissues was isolated with TRIzol
reagent according to the manufacturer’s instructions.
Lentivirus Infection and Construction of Stable Cell Lines with
Downregulated lncRNA-AK058003
To observe the effects of AK058003 knockdown on invasion and
metastasis in vivo and in vitro, four different small interfering RNAs
(siRNAs) that targeted AK058003 RNA and a scrambled siRNA
control were generously provided by GenePharma (Shanghai, China).
The four siRNAs were transfected into SGC7901 and MKN45 cells
using Lipofectamine 2000 (Invitrogen) following the manufacturer's
protocol. Twenty-four hours after transfection, AK058003 expression
levels were measured through reverse transcriptase polymerase chain
reaction (RT-PCR), and we found that siRNA-AK1 with the
sequence 5’-CCACCAGUUACCUGCAAUATT-3’ (sense) and 5’-
UAUUGCAGGUAACUGGUGGTT-3’ (antisense) and siRNA-
AK2 with the sequence 5’-GGAACAAAGAUGGUUUCUATT-3’
(sense) and 5’- UAGAAACCAUCUUUGUUCCTT-3’ (antisense)
yielded the highest degree of AK058003 knockdown. Then, we designed
and synthesizedAK058003-targeting sequence and inserted this sequence
into a Supersilencing Vector (GenePharma, Shanghai, China). An
unrelated sequence lentiviral vector was used as a negative control.
SGC7901 and MKN45 cells were then plated into six-well plates and
allowed to adhere for 24 hours. Next, the lentivirus was transfected
according to the manufacturer’s instructions. Stably transfected cells were
selected with puromycin (Sigma-Aldrich, St. Louis, MO) and confirmed
through fluorescence microscopy and RT-PCR.
Oligonucleotide Construction
siRNAs targeting SNCG were synthesized by GeneChem
(Shanghai, China), and a scrambled siRNA control was used as a
negative control (provided by GeneChem). The sequence for the
SNCG siRNA was 5’-CCAAGGAGAATGTTGTACA-3’. The cells
were transfected using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions.
Plasmid Construction
The full length of SNCG was amplified (forward primer: 5’-
G A T A TGA ATTCGCCACCATGGATGTCTTCA A
GAAGGGCTTCTCC-3’; reverse primer: 5’-GTATCGGATCCC
TAGTCTCCCCCACTCTGG-3’) and then cloned into the pEX-2
vector. After digestion with EcoRI and BamHI, the correctness of the
construct was confirmed by sequencing. An empty vector was used as
a negative control.
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For transwell migration assays, 5×104 cells in serum-free RPMI
1640 medium were added to the upper chamber of each insert (BD
Biosciences, Franklin Lakes, NJ). For invasion assays, the chamber
inserts were coated with 50 mg/l Matrigel (BD Biosciences, San Jose,
CA). After 4 to 5 hours of incubation at 37°C, 1×105 cells in serum-
free RPMI-1640 medium were added to the upper chamber. In both
assays, medium supplemented with serum was used as a chemoat-
tractant in the lower chamber. After incubation in a normoxia (37°C
and 5% CO2) or hypoxia (37°C, 1% O2, 5% CO2, and 94% N2)
chamber for 24 or 48 hours, the cells on the upper surface were
removed, and the cells on the lower surface of the membrane were
fixed in 100% methanol for 15 minutes, air dried, stained with 0.1%
crystal violet, and counted under a microscope (Olympus Corp.,
Tokyo, Japan) to calculate relative numbers. Nine random fields were
analyzed per insert. Each experiment was conducted in triplicate in
three independent experiments.
High-Content Screening Assay
Briefly, 5×103 cells were plated into each well of a 96-well plate
and incubated at 37°C. After 24 hours, the culture medium was
replaced with serum-free RPMI 1640 medium, and the cells were
cultured for an additional 24 hours. The cells were then washed twice
with ice-cold phosphate-buffered saline (PBS) and stained with
Hoechst 33342 for 15 minutes in an incubator. The cells were
subsequently washed twice with ice-cold PBS, and culture medium
was added to each well. Cell motility was detected with a Cellomics
ArrayScan VTI HCS (Thermo Scientific, Waltham, MA) according
to the manufacturer’s instructions (five replicate wells per group).
Wound-Healing Assays
SGC7901-siAK or SGC7901-Scr and MKN45-siAK or MKN45-
Scr cells were seeded in six-well plates and incubated until 90%
confluence in serum-free medium before wounding. A 200-μl tip was
used to make a vertical wound, and the cells were then washed three
times with PBS to remove cell debris. Cell migration into the
wounded area was monitored by microscopy at the designated times.
In Vivo Metastasis Assays
Nude mice were purchased from the Experimental Animal Center
of the Fourth Military Medical University. For in vivo metastasis
assays, 2×106 SGC7901 and MKN45 cells infected with a lentivirus
containing AK058003 siRNA and a negative control were suspended
in 0.2 ml PBS and injected into the tail vein of each mouse. After 6
weeks, the mice were sacrificed, and their tumor nodules were
counted under a stereomicroscope (Olympus). The tumor tissues
derived from various organs were then dissected and histologically
examined. Each tumor cell line was injected into 10 mice.
Bisulfite Sequencing PCR Analyses
Genomic DNA was extracted from GC cells with the QIAamp DNA
Mini Kit (Qiagen, Valencia, CA) and subjected to bisulfite modification
using an EpiTect Bisulfite kit (Qiagen) according to the manufacturer’s
protocol. We used Methyl Primer Express v1.0 to design primers on
bisulfite-treated DNA.The primer is forward: 5'-GTTGTTTTGGGA
TAGGGGTT-3' and reverse: 5'-CCRCAAACAAAAAAATACAAA-3'.
PCR was performed in a final volume of 25 ml containing ddH2O
19.5μl, 10× PCR buffer 2.5μl, dNTP Mix 0.5μl, 0.5μl of each primer,
0.5μl rTaq, and 1μl DNA. PCR was carried out at 94°C for 5 minutes;
40 cycles at 94°C for 30 seconds, 58°C for 30 seconds, and 72°C for30 seconds; and finally 72°C for 10 minutes. The PCR product was
ligated into T Vector. After transformation, individual colonies were
picked, and the insert was sequenced and analyzed by BiQ_Analyzer.
Statistical Analyses
The SPSS 12.0 program (SPSS Inc., Chicago, IL) was used for
statistical analyses. The data are presented as the mean±standard error
for at least three independent experiments. The differences between
groups were analyzed using Student’s t test when comparing only two
groups or one-way analysis of variance when comparing more than
two groups. The chi-square test was used to analyze the relationship
between SNCG expression and various clinicopathologic character-
istics. AK058003 and SNCG expression levels in clinical GC tissues
and corresponding adjacent nontumorous tissues were compared
using the Wilcoxon signed-rank test. Correlations between
AK058003 and SNCG expression in tissue specimens were explored
using Pearson’s correlation. P b .05 was considered significant.
A detailed description of the materials and methods used in this
study can be found in the Supporting Materials.
Results
lncRNA Expression Profile in Hypoxia-Induced GC Cells
To examine the overall impact of lncRNAs on hypoxic GC, we
analyzed the expression profiles of lncRNAs and protein-coding
RNAs in normoxia-induced and hypoxia-induced GC cells using
microarray analysis. Scatter and volcano plots are shown in Figure S1.
Hierarchical clustering showed the differential lncRNA and protein-
coding RNA expression profiles between normoxia-induced and
hypoxia-induced GC cells (Figure 1, A and B). We set a threshold of
a fold change N1.5, P b .05, and found that 84 lncRNAs were
upregulated and 70 were downregulated in all hypoxia-induced GC
cells compared with normoxia-induced GC cells (Figure 1, C and D;
Supplementary Tables 3 and 4). This finding indicated that the
lncRNA expression profiles differed between the two groups.
To validate the microarray findings, we randomly selected six
lncRNAs from the differentially expressed lncRNAs with a fold
change N3 and analyzed their expression through real-time PCR with
hypoxia-induced GC cells (after 24 hours in 1% O2 for the
SGC7901, MKN45, and MKN28 GC cells) relative to normoxia-
induced GC cells. The expression of most lncRNAs was consistent
with the microarray results (Figure S2, Supplementary Table 1),
indicating that a set of lncRNAs is frequently aberrantly expressed in
hypoxia-induced GC cells.
Newly Identified AK058003 Frequently Upregulated in GC
and Induced by Hypoxia in GC Cells
Among the differentially expressed lncRNAs among hypoxia-
induced GC cells and normoxia-induced GC cells, we were
particularly interested in lncRNA-AK058003 because its expression
increased approximately 6.20±1.65-fold upon hypoxia treatment in
all three cell lines. Thus, we studied the role of AK058003, which is
an intronic antisense lncRNA.
Given that AK058003 is induced by hypoxia in GC cells, we next
sought to determine whether AK058003 could be induced by
hypoxia at different exposure times (after 4, 8, 16, 24, and 48 hours in
1% O2) in GC cells. We found that AK058003 was induced under
hypoxia, with the most robust induction observed after 16 hours in
1% O2 for SGC7901 cells, 24 hours in 1% O2 for MKN45 cells, and
48 hours in 1% O2 for MKN28 cells (Figure 2, A–C). The results
Figure 1.Differentially expressed lncRNAs (A) and mRNAs (B) were analyzed using hierarchical clustering. Hierarchical clustering analysis
arranges samples into groups based on expression levels, which allows us to hypothesize the relationships between samples. The
dendrogram shows the relationships between the lncRNA (A) and mRNA (B) expression patterns in the samples, that is, which samples
are more similar in the expressing relationships. For every gene in each sample, the “Red” indicates high relative expression, and “Blue”
indicates low relative expression. Actually, there is no inevitable relation between the lncRNA shown in A and mRNA presented in B
expression patterns in the samples because they were analyzed independently. Schemas of the upregulated (C) and downregulated (D)
lncRNAs, identified by microarray in the GC cells SGC7901, MKN45, and MKN28 under hypoxia. The overlapping areas represent the
common lncRNAs in all three GC cell lines under hypoxia.
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cells; however, no significant difference was observed in expression
after 4 or 8 hours in 1% O2.
Next, we assessed AK058003 expression in 95 pairs of human
primary GC tissues and adjacent gastric tissues using quantitative RT-
PCR to determine AK058003 expression in GC tissues. AK058003
expression was remarkably upregulated in GC tissues compared with
noncancerous gastric tissues (Figure 2D), indicating that AK058003
upregulation is common in GC.
Effect of AK058003 on GC Cell Migration and Invasion and
Hypoxia-Induced Migration and Invasion
The frequent AK058003 upregulation in hypoxic GC cells implies
that AK058003 may play a role in hypoxia-induced GC. To test this
hypothesis, the effects of reduced AK058003 expression on cell
proliferation, migration, and invasion were investigated in two GC
cell lines. Four different siRNA molecules were tested for their
knockdown efficiencies, and the two most efficient of these molecules
(siRNA-AK1 and siRNA-AK2) were selected for subsequent studies
(Figure 3, A and B). We first established SGC7901 and MKN45 cell
lines that stably repressed AK058003 expression by using an
AK058003 siRNA-lentivirus (si-AK) vector, as verified by fluores-
cence microscopy (Figure 3C) and RT-PCR (Figure 3D). However,3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide
and colony-forming assays showed that AK058003 downregulation
did not significantly affect cell proliferation (Figure S3).
To investigate whether AK058003 might have a role in hypoxia-
induced metastasis, we first determined whether AK058003 affected
normoxic GC cell migration and invasion. In transwell assays with or
without Matrigel, SGC7901 and MKN45 cells with stable AK058003
knockdown showed significantly decreased migration and invasion
compared with control cells (Figure 3, E and F). Moreover, we examined
cell motility in different groups under normoxia using high-content
screening, which indicated that cell motility was reduced in AK058003
siRNA-lentivirus–treated cells compared with scrambled siRNA–treated
cells (Figure 3, G and H). Taken together, these results indicate that
although AK058003 did not affect GC cell growth, the lncRNA
promoted migration and invasion.
Given that AK058003 can promote normoxic GC cell migration
and invasion, we hypothesized that AK058003 might play a role in
hypoxia-induced migration and invasion. To test this hypothesis, we
first measured hypoxic GC cell migration and invasion. Hypoxia
significantly increased the migration and invasion potential of
SGC7901 and MKN45 cells (Figure 4, A–D), which is consistent
with previous reports [4,5]. After transfection with a siRNA-lentivirus
to decrease endogenous AK058003 expression, the hypoxia-induced
Figure 2. AK058003 is often upregulated in GC and is induced by hypoxia in GC cells. (A, B, C) AK058003 was induced under hypoxia, with
the most robust induction observed after 16 hours in 1% O2 in (A) SGC7901 cells, 24 hours in 1% O2 in (B) MKN45 cells, and 48 hours in
1% O2 in (C) MKN28 cells. (D) RNA was extracted with TRIzol reagent from 95 pairs of human GC and adjacent tissues. AK058003
expression was assessed by real-time PCR. β-Actin was used as an internal control. The significant differences between samples were
analyzed using the Wilcoxon signed-rank test (P = .002, n = 95).
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dramatically diminished (Figure 4, A–D). In addition, wound-healing
assays showed that, under hypoxia, the cells more rapidly closed
wounds (Figure 4, E–H). However, after AK058003 knockdown in
GC cells, wound healing was not significantly promoted under
hypoxia compared with the control cells (Figure 4, E–H).
To further explore the role of AK058003 in tumor invasion and
metastasis in vivo, SGC7901 and MKN45 cells with stable AK058003
repression by an AK058003 siRNA-lentivirus or a scrambled siRNA
vector-transfected control cells were delivered into nude mice via tail
vein injection. We found that the number and size of lung and liver
metastatic nodules dramatically decreased in mice administered cells
with low AK058003 expression compared with the scrambled siRNA
controls (Figure 4, G–J). Taken together, these observations suggest
that AK058003 is a positive metastatic regulator of GC.
SNCG an AK058003-Regulated Gene in GC
To explore the mechanism by which AK058003 promotes GC cell
migration and invasion, we attempted to identify the lncRNA’s
potential target genes. Recent studies have reported that lncRNAs
may function by positively or negatively regulating the expression of
their neighboring protein-coding genes [14,16,26–28].Thus, we
retrieved the genomic locus information from the UCSC genome
browser (http://genome.ucsc.edu/) and found that the tumor
oncogene SNCG is located 8.6 kb downstream of AK058003,
whereas another tumor suppressor gene, BMPR1A, is found 33.3 kb
upstream of AK058003 (Figure 5A). To validate the association
between the lncRNA AK058003 and BMPR1A or SNCG, weperformed RT-PCR and western blotting using SGC7901 and
MKN45 cells with AK058003 knockdown. BMPR1A expression was
unchanged (data were not shown), whereas we observed significantly
decreased SNCG levels in cells with low AK058003 expression
compared with scrambled siRNA control cells (Figure 5, B–E) (This
SNCG is a monomer; the molecular weight of the bands in the figure
is approximately 16 kDa, predicted molecular weight: 13 kDa
(Abcam, Cambridge, MA, Cat. #: ab52633)). Moreover, we showed
that AK058003 suppressed SNCG mRNA and protein levels in GC
cells and that there was a dose-dependent relationship between the
expression of SNCG and AK058003 (Figure 5, B–E). These results
suggest that SNCG is an AK058003-regulated gene in GC. We also
found that SNCG was predominantly located in the cytoplasm of GC
cells. Moreover, we found that SNCG expression was heterogeneous
in tumor tissue; it was predominantly located in the center of the
tumor but had almost negative expression in the stroma of GC tissues.
There was little SNCG expression in paracancerous tissues. These
results confirmed that SNCG protein levels in GC tissue were
significantly higher than in paracancerous tissues. Additional analysis
revealed that SNCG showed strong staining at primary sites from
patients with metastatic GC compared with samples from patients
with nonmetastatic GC (Figure 6A). Next, we analyzed the correlation
between SNCG expression and the clinicopathologic parameters of GC
patients. As shown in Supplementary Table 5, SNCG overexpression
was associated with the depth of tumor invasion, the clinical tumor
nodemetastasis stage, lymph nodemetastasis, and vascular invasion (Pb
.001 for all by the Mann-Whitney test). SNCG expression in GC
patients did not correlate with age, sex, or cell differentiation.
Figure 3. AK058003 promotes GC cell migration and invasion. (A, B) AK058003 expression following knockdown by four different siRNA
(si-AK1, si-AK2, si-AK3, and si-AK4) in the GC cell lines SGC7901 (A) and MKN45 (B). (C) Observation of the infection efficiency of
AK058003 (si-AK1 and si-AK2) and scrambled siRNA lentivirus (si-Scr) by fluorescence microscopy. (D) After transfection, the cells were
collected, and AK058003 expression was assessed by RT- PCR. (E, F) Transwell migration (E) and invasion (F) assays of SGC7901 and
MKN45 cells were performed after transfection with AK058003 si-AK1 and si-AK2 or a scrambled siRNA control (si-Scr). (G, H) Cell mobility
was examined with a Cellomics ArrayScan VTI 1700 Plus. The relative distance traveled because of SGC7901 (G) and MKN45 (H) cell
mobility was calculated with this instrument. In all panels, the results are representative of at least three independent experiments.
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SNCG expression in 95 clinical GC tissues and found that AK058003
and SNCG expression levels were positively correlated (Figure 5F). These
observations indicate that SNCG is frequently upregulated in GC
samples, possibly because of AK058003 overexpression.
Next, to investigate the potential mechanism by which AK058003
contributes to malignant behaviors of GC cells, we focused on DNA
methylation of SNCG because lncRNAs are known to be involved in
epigenetic regulation and DNA hypomethylation of SNCG has beenconfirmed in laryngeal cancer, including GC. Then, we performed
bisulfite sequencing of cloned alleles over the region of −169 to 81 of
the SNCG exon1 CpG islands, which has been demonstrated to be
involved in GC [29]. The results showed that SNCG CpG islands
were densely hypomethylated in control SGC7901-si-Scr and
MKN45-si-Scr cells, but GC cells transduced with AK058003
siRNA showed more methylated CpG dinucleotides (Figure 5G).
Taken together, these results indicate that knockdown of AK058003
can downregulate the expression of SNCG in GC cells by regulating
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downstream target of AK058003 in GC cells.
SNCG Mediates AK058003-induced Migration and Invasion
of GC Cells
To further explore the biological function of SNCG in GC,
siRNAs targeting SNCG were designed and transfected into
SGC7901 and MKN45 cells. These siRNAs significantly decreased
SNCG expression (Figure 6C). The migration and invasion of the
two cell lines were significantly decreased by SNCG siRNA but not
by the scrambled siRNA control (Figure 6, B and C). To support
these findings, we overexpressed SNCG in SGC7901 and MKN45
cells, which significantly increased cell migration and invasion
(Figure 6, D and E).
If SNCG is indeed a functional gene of AK058003 in GC, then
SNCG restoration in AK058003-downregulated GC cells should
abrogate the effects of AK058003. To test this hypothesis, we
introduced an SNCG expression vector into SGC7901 and MKN45
GC cells that had reduced AK058003 expression, restoring SNCG
protein level (Figure 6, F–I). After SNCG restoration, the migration
and invasion of SGC7901 and MKN45 cells that were previously
inhibited by si-AK058003 significantly increased. These results
indicate that SNCG is a functional gene of AK058003 in GC cells.
SNCG Regulation by AK058003 Mediates Hypoxia-Induced
GC Metastasis
To determine whether SNCG is involved in AK058003-induced
hypoxic GC cell metastasis, we first detected SNCG expression under
hypoxia. The results showed that SNCG expression in GC cells
increased under hypoxia compared with normoxia (Figure 7, A and
B; upper panel). When AK058003 expression was downregulated in
SGC7901 and MKN45 cells, the hypoxia-induced SNCG increase
was abrogated (Figure 7, A and B; lower panel), indicating that
SNCG overexpression was mediated by AK058003 upregulation
under hypoxia. Moreover, transwell assays indicated that inhibiting
SNCG expression promoted hypoxia-induced migration and invasion
(Figure 7, C–F). To determine the function of SNCG in AK058003-
induced GC metastasis under hypoxia, an SNCG expression vector
and a scramble control were cotransfected into SGC7901 andMKN45
cells with stable AK058003 suppression. In transwell experiments, the
impairment of the effects of siRNA-mediated AK058003 on hypoxia-
inducedGC cellmigration and invasionwas partially relieved by SNCG
but not by the negative control (Figure 7, G–J). Taken together, these
results indicate that SNCG expression is increased by hypoxia and thatFigure 4. AK058003mediates hypoxia-induced GC cell migration and i
cells were performed after transfection with AK058003 siRNA-lentivi
normoxic or hypoxic conditions. (C, D) Transwell migration and invas
AK058003 siRNA-lentivirus (si-AK1 and si-AK2) or a scrambled siRNA
the results are representative of at least three independent experime
effect of AK058003 expression on cell migration. Cell culture plates w
and si-AK2) or a scrambled siRNA control (si-Scr). MKN45 cells (F) that
siRNA control (si-Scr). Cells were wounded and incubated under norm
times. (H, J) The incidence of metastasis in mice (left panel) and the
panel) due to SGC7901-transfected cells (H) and MKN45-transfected c
the AK058003 siRNA-lentivirus (si-AK1 and si-AK2) or a scrambled siR
AK058003 siRNA-lentivirus (si-AK1 and si-AK2) or a scrambled siRNA
tail vein for an in vivo metastasis assay, and the animals were sacrif
eosin staining of lungs and livers isolated from mice injected with
MKN45-si-AK cells (I). The arrows indicate tumor foci in the lungs anSNCG upregulation by AK058003 mediates hypoxia-induced GC
metastasis.Discussion
Hypoxia is an important microenvironmental factor in nearly every
solid tumor, including GC, and it is related to an increased risk of
metastasis and invasion [30]. The contribution of hypoxia-induced
signaling pathways to malignancy is of great interest [31,32]. Our
previous studies found that many protein-coding genes associated
with hypoxia correlation with GC metastasis and invasion [4–6].
However, the exact mechanism in this process has not been thoroughly
elucidated. Recently, mounting evidence suggests that the expression of
many lncRNAs is altered in different types of human cancer [33]. Fu
Yang et al. demonstrated that a hypoxic microenvironment suppresses
lncRNA-LET, which was associated with HepatoCellular Carcinoma
metastasis [10]. In another study, Fan Yang et al. found that lincRNA-
p21 is a hypoxia-responsive lncRNA and is essential for hypoxia-
enhanced glycolysis [34]. However, whether lncRNA is also involved in
the hypoxic GC remains uncharacterized. In this study, as a first attempt
to investigate whether lncRNA expression is altered under hypoxic
conditions, we first searched for potential hypoxia-responsive lncRNAs
using lncRNA microarrays between hypoxia-induced GC cells and
normoxia-induced GC cells. The results showed that hypoxia alters
lncRNA expression and indicate that hypoxic GC may have specific
lncRNA profiles. We then selected six lncRNAs from the differentially
expressed lncRNAs with a fold change N3 and performed a quantitative
RT-PCR to examine these lncRNAs’ expression levels inGC cells under
both normoxic and hypoxic conditions. Of these six lncRNAs, only
AK058003, which is a 1197-bp transcript and is located in the
chromosome 10q22 on the forward strand, was strongly induced by
hypoxia in three GC cells and upregulated in GC samples. In addition,
lncRNA-AK058003 was induced by hypoxia at a time-dependent
manner in different GC cells. These data indicate the specificity of
lncRNA-AK058003 in hypoxic induction. Moreover, we found that
AK058003 mediated hypoxia-induced GC migration and invasion in
vitro and in vivo. To our knowledge, this study is the first report
demonstrating that an lncRNA enhances GC cell migration and invasion
under hypoxia. Thus, our results suggest that lncRNA-AK058003
may not only act as a tumor hypoxia marker or adjust cells to hypoxic
stress in tumors but may also have a biological role in tumor malignancy
and metastasis.
However, the mechanism of lncRNAs in hypoxic cancer has not
been thoroughly elucidated. Several reports have demonstrated thatnvasion. (A, B) Transwell migration and invasion assays of SGC7901
rus (si-AK1 and si-AK2) or a scrambled siRNA control (si-Scr) under
ion assays of MKN45 cells were performed after transfection with
control (si-Scr) under normoxic or hypoxic conditions. In all panels,
nts. (E, F) Wound-healing assays were performed to evaluate the
ith SGC7901 cells (E) that were transfected with AK058003 (si-AK1
were transfected with AK058003 (si-AK1 and si-AK2) or a scrambled
oxic or hypoxic conditions. Healing was determined at the indicated
mean number of visible tumor nodules in the liver and lung (right
ells (J) (n= 10 per group). (H) SGC7901 cells were transfected with
NA control (si-Scr), and (J) MKN45 cells were transfected with the
control (si-Scr). The cells were then injected into nude mice via the
iced 6 weeks after injection. (G, I) Representative hematoxylin and
SGC7901-si-Scr or SGC7901-si-AK cells (G) and MKN45-si-Scr or
d livers. Magnification, ×100 (left) and ×200 (right).
Figure 5. AK058003 upregulates SNCG inGC cells. (A) A diagramof the genes located aroundAK058003. (B–E) ThemRNA (B, D) and protein (C,
E) levels of SNCG were assessed through RT-PCR and Western blotting, respectively, in SGC7901 and MKN45 cells transfected with an
AK058003 siRNA-lentivirus (si-AK1 and si-AK2) or a scrambled siRNA control (si-Scr) in a dose-dependent manner. (F) Correlation between the
relativemRNA levels of AK058003 andSNCG in 95GC tissue specimens (r=0.5262,Pb .001, Pearson’s correlation). (G)Methylationmapping of
15 CpG island in SNCG exon 1 region obtained from bisulfite sequencing in scrambled siRNA control MKN45 or SGC7901 cells, andMKN45 or
SGC7901cells infected with AK058003 siRNA. CpG positions are indicated relative to the translation start codon, and each circle in the figure
represents a single CpG site. For each cell line, the percentage methylation at a single CpG site is calculated from the sequencing results of 10
independent clones. Black circles, 100% methylated; white circles, 0% methylation.
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nearest protein-coding genes and that these lncRNAs may have either
a positive [26,35] or negative [14,16] effect on gene expression.
Accordingly, we were interested in the genes surrounding AK058003.
We then retrieved the genomic locus information and found that the
SNCG gene, which is a prometastatic oncogene, is only approx-
imately 8.6 kb downstream from the AK058003 gene.
SNCG was first discovered by direct differential cDNA sequencing
in breast cancer samples [36] and can promote breast cancer
metastasis and invasion [37]. Certain studies have revealed a strong
correlation between SNCG expression in primary tumors and distant
metastasis in many cancer types, including liver, esophageal, colon,
gastric, lung, prostate, and cervical cancers [38]. Furthermore, SNCG
expression may be related to the tumor microenvironment [39]. In
our study, we found that SNCG expression is increased in GC
samples, particularly in metastatic tissues, and promotes GC
metastasis. After analyzing the relationship between SNCG expres-
sion and the clinicopathologic factors of GC patients, we found asignificant association between SNCG expression and the depth of
tumor invasion, clinical tumor node metastasis stage, lymph node
metastasis, and vascular invasion. Moreover, we observed that SNCG
was also involved in hypoxia-induced GC metastasis. Furthermore,
we found that the SNCG mRNA levels were positively correlated
with the expression of AK058003 in 95 pairs of clinical GC samples.
Accordingly, we have found that AK058003 knockdown could
downregulate SNCG expression at the mRNA and protein levels in a
dose-dependent manner. These data demonstrated that SNCG
downregulation is at least partly caused by AK058003 downregula-
tion in GC.
However, the mechanism of AK058003 regulation of SNCG is
still unknown. Surgucheva et al. demonstrated that mature miRs
repress protein expression primarily through base pairing of a seed
region with the 3’-UTR of SNCG [40]. Furthermore, several studies
reported that SNCG expression is activated by demethylation of the
SNCG CpG island in the development of cancer, including GC
[29,41,42]. In another study, H. Liu et al. found that cigarette smoke
Figure 6. SNCG functions as a metastasis-related gene in GC and can promote AK058003-induced GC cell migration and invasion.
(A) Immunohistochemical analysis of SNCG in metastatic and nonmetastatic GC: (a) noncancerous region of GC, (b) primary site of
nonmetastatic GC, (c, d) primary site of metastatic GC, and (e) breast cancer as positive control. (B, C) Transwell migration and invasion
assays of SGC7901 and MKN45 cells were performed after transfection with siRNA directed against SNCG or a scrambled siRNA control
(si-Scr). SNCG protein levels were detected by Western blot analysis as well (at bottom of Figure C). (D, E) Transwell migration and
invasion assays of SGC7901 and MKN45 cells were performed after transduction with SNCG or a negative control. SNCG protein levels
were detected by Western blot analysis as well (at bottom of E). (F, G, H, I) Transwell migration and invasion assays of SGC7901-si-Scr or
SGC7901-si-AK cells (F, G) and MKN45- si-Scr and MKN45-si-AK cells (H, I) were performed after transduction with a scrambled siRNA
control (si-Scr) or SNCG. SNCG protein was detected by Western blot analysis as well (at bottom of G and I). In all panels, the results are
representative of at least three independent experiments.
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Figure 7. Restoration of SNCG significantly increased the GC cell migration and invasiveness inhibited by AK058003 knockdown under
hypoxia. (A, B) SNCG protein levels in SGC7901 andMKN45 cells. The cells were transfected with an AK058003 siRNA-lentivirus (si-AK) or
a scrambled siRNA control (si-Scr) and then exposed to hypoxia after transfection. The cells were then collected and subjected toWestern
blot analysis at specific time points, as indicated. β-Actin served as an internal control. (C, D, E, F) Transwell migration and invasion assays
of SGC7901-si-Scr and SGC7901-si-SNCG cells (C, D) and MKN45-si-Scr and MKN45-si-SNCG cells (E, F) were performed under normoxic
or hypoxic conditions. SNCG protein levels were determined by Western blot assays as well (at bottom of D and F). (G, H, I, J) Transwell
migration and invasion assays of SGC7901 (G, H) and MKN45 (I, J) cells were performed after transfection with an AK058003 siRNA-
lentivirus (si-AK), SNCG expression vector, or a scrambled siRNA control (si-Scr) under normoxic or hypoxic conditions. SNCG protein
levels were determined through Western blot assays as well (at bottom of H and J). In all panels, the results are representative of at least
three independent experiments.
1104 lncRNA-AK058003 Promotes Gastric Cancer Metastasis Wang et al. Neoplasia Vol. 16, No. 12, 2014induces the demethylation and subsequent expression of SNCG gene
in lung cancer cells through downregulation of DNA methyltrans-
ferase 3B [43]. Recently, increasing evidence confirmed that lncRNA
can regulate DNA methylation of protein-coding genes during the
development of disease [22,35,44,45]. For instance, in a recent paper
published in Nature, Di Ruscio and colleagues reported that the
lncRNA-ecCEBPA interacts with DNAmethyltransferase 1, resulting
in prevention of CEBPA gene methylation and robust CEBPA
mRNA production [35]. Wei Li et al. demonstrated that linc-
POU3F3 promotes cell viability and proliferation in esophageal
squamous cell carcinoma cell levels and altered linc-POU3F3 levels
could drive the methylation of the POU3F3 gene, which is located inthe downstream of 4 kb from the linc-POU3F3 [46]. Because SNCG
gene is subject to silencing by DNA methylation, we assessed whether
depletion of AK058003 resulted in changes in DNA methylation of
SNCG. Interestingly, using Bisulfite sequencing PCR assays, we
observed a robust increase in levels of DNA methylation of SNCG
following the depletion of AK058003.
Furthermore, we have observed that SNCG overexpression was
mediated by AK058003 upregulation under hypoxia and that the
SNCG upregulation by AK058003 mediates hypoxia-induced GC
metastasis. This finding indicated that hypoxia/AK058003/SNCG is
a new signaling pathway involved in hypoxia-induced GC metastasis
and invasion.
Neoplasia Vol. 16, No. 12, 2014 lncRNA-AK058003 Promotes Gastric Cancer Metastasis Wang et al. 1105In conclusion, our results indicated that lncRNA-AK058003
expression is frequently increased in hypoxic GC and promotes
hypoxia-induced GC metastasis and invasion. SNCG, a metastasis-
associated gene in cancer that is involved in hypoxia-induced GC
metastasis, was identified as a functional gene that was regulated by
AK058003 through DNA demethylation. SNCG upregulation by
AK058003 mediates hypoxia-induced GC cell migration and
invasion. Further study will explore the exact mechanism of SNCG
DNA demethylation that is induced by AK058003. In summary, this
finding suggests that the hypoxia/AK058003/SNCG pathway may
contribute to the development of new anticancer therapeutics
directed against hypoxic tumor targets.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2014.10.008.
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